» Articles » PMID: 37228671

Multimodal AI for Prediction of Distant Metastasis in Carcinoma Patients

Overview
Journal Front Bioinform
Specialty Biology
Date 2023 May 25
PMID 37228671
Authors
Affiliations
Soon will be listed here.
Abstract

Metastasis of cancer is directly related to death in almost all cases, however a lot is yet to be understood about this process. Despite advancements in the available radiological investigation techniques, not all cases of Distant Metastasis (DM) are diagnosed at initial clinical presentation. Also, there are currently no standard biomarkers of metastasis. Early, accurate diagnosis of DM is however crucial for clinical decision making, and planning of appropriate management strategies. Previous works have achieved little success in attempts to predict DM from either clinical, genomic, radiology, or histopathology data. In this work we attempt a multimodal approach to predict the presence of DM in cancer patients by combining gene expression data, clinical data and histopathology images. We tested a novel combination of Random Forest (RF) algorithm with an optimization technique for gene selection, and investigated if gene expression pattern in the primary tissues of three cancer types (Bladder Carcinoma, Pancreatic Adenocarcinoma, and Head and Neck Squamous Carcinoma) with DM are similar or different. Gene expression biomarkers of DM identified by our proposed method outperformed Differentially Expressed Genes (DEGs) identified by the DESeq2 software package in the task of predicting presence or absence of DM. Genes involved in DM tend to be more cancer type specific rather than general across all cancers. Our results also indicate that multimodal data is more predictive of metastasis than either of the three unimodal data tested, and genomic data provides the highest contribution by a wide margin. The results re-emphasize the importance for availability of sufficient image data when a weakly supervised training technique is used. Code is made available at: https://github.com/rit-cui-lab/Multimodal-AI-for-Prediction-of-Distant-Metastasis-in-Carcinoma-Patients.

Citing Articles

Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Iancu D, Fulga A, Vesa D, Fulga I, Tutunaru D, Zenovia A Clin Pract. 2025; 15(1).

PMID: 39851804 PMC: 11764338. DOI: 10.3390/clinpract15010021.


Head and Neck Squamous Cell Carcinoma with Distant Metastasis: A Systematic Review and Meta-Analysis.

Daloiso A, Franz L, Mondello T, Tisato M, Negrisolo M, Zanatta P Cancers (Basel). 2024; 16(22).

PMID: 39594842 PMC: 11592668. DOI: 10.3390/cancers16223887.


Deep neural networks integrating genomics and histopathological images for predicting stages and survival time-to-event in colon cancer.

Ogundipe O, Kurt Z, Woo W PLoS One. 2024; 19(9):e0305268.

PMID: 39226289 PMC: 11371203. DOI: 10.1371/journal.pone.0305268.


Applications of Multimodal Artificial Intelligence in Non-Hodgkin Lymphoma B Cells.

Isavand P, Aghamiri S, Amin R Biomedicines. 2024; 12(8).

PMID: 39200217 PMC: 11351272. DOI: 10.3390/biomedicines12081753.

References
1.
Wang C, Wang L, Wu C, Chen M, Kuo C, Shyu R . Cathepsin V Mediates the Tazarotene-induced Gene 1-induced Reduction in Invasion in Colorectal Cancer Cells. Cell Biochem Biophys. 2020; 78(4):483-494. DOI: 10.1007/s12013-020-00940-3. View

2.
Yang J, Liu W, Lu X, Fu Y, Li L, Luo Y . High expression of small GTPase Rab3D promotes cancer progression and metastasis. Oncotarget. 2015; 6(13):11125-38. PMC: 4484444. DOI: 10.18632/oncotarget.3575. View

3.
He Q, Fornander T, Johansson H, Johansson U, Hu G, Rutqvist L . Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer. Anticancer Res. 2007; 26(6C):4753-9. View

4.
Jen J, Wang Y . Zinc finger proteins in cancer progression. J Biomed Sci. 2016; 23(1):53. PMC: 4944467. DOI: 10.1186/s12929-016-0269-9. View

5.
Hennigs J, Minner S, Tennstedt P, Loser R, Huland H, Klose H . Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer. Sci Rep. 2020; 10(1):3250. PMC: 7039909. DOI: 10.1038/s41598-020-60064-9. View